Modern oncology has advanced from analyzing bulk tissue to mapping the entire tumor ecosystem in high definition. By combining liquid biopsies (ctDNA) and spatial transcriptomics, researchers can track tumor evolution non-invasively while preserving the microenvironment's exact structural architecture. Meanwhile, cutting-edge single-cell proteogenomics and epigenetics (scATAC-seq) enable scientists to detect real-time translation changes and structural chromatin flips. This reveals how single rogue cells develop drug resistance before clinical symptoms appear.
NucleoSpin cfDNA XS, Micro kit for cell-free DNA from plasma
Content 50 Preps
Exosome Precipitation Solution for enrichment of exosomes from serum or plasma
Content 12 mL
NucleoMag cfDNA kit for cell-free DNA purification from plasma
Content 192 Preps
NucleoBond CB 100, Midi kit for high integrity DNA from cells and blood
Content 20 Preps
NucleoBond CB 20, Midi kit for high integrity DNA from cells and blood
Content 20 Preps
NucleoBond CB 500, Midi kit for high integrity DNA from cells and blood
Content 10 Preps
Exosome Precipitation Solution for enrichment of exosomes from urine
Content 50 mL
NucleoSpin 96 cfDNA, 96-well kit for cell-free DNA from plasma
Content 384 Preps
NucleoSpin 96 cfDNA Core Kit, 96-well kit for cell-free DNA from plasma
Content 384 Preps
NucleoSpin cfDNA Midi Core Kit for cell-free DNA from plasma
Content 48 Preps